Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
09/2005
09/21/2005EP1577295A1 Process for preparing 2-oxo-1-pyrrolidine derivatives as intermediates
09/21/2005EP1576159A1 The gene cluster involved in safracin biosynthesis and its uses for genetic engineering
09/21/2005EP1575964A2 N-(benzyl)aminoalkyl carboxylate, phosphinates, phosphonates and tetrazoles as edg receptor agonists
09/21/2005EP1575945A1 Oxazolidinone derivatives as antibacterial
09/21/2005EP1575944A1 Oxazolidinone derivatives as antibacterial agents
09/21/2005EP1575940A1 2,4,6-trisubstituted pyrimidines as phosphotidylinositol (pi) 3-kinase inhibitors and their use in the treatment of cancer
09/21/2005EP1575933A1 Enantiomers of thiophene hydroxamic acid derivatives and their use as hdac inhibitors
09/21/2005EP1575926A1 New pyridazin-3(2h)-one derivatives
09/21/2005EP1575925A1 Novel carboxamides, the production and use thereof as medicaments
09/21/2005EP1575924A1 4-substituted benzimidazoles and their use as inhibitors of gastric secretion
09/21/2005EP1575918A2 Substituted biaryl-4-carboxylic acid arylamide analogues as capsaicin receptor modulators
09/21/2005EP1575900A1 N-methyl amino acids
09/21/2005EP1575495A2 Compounds and methods
09/21/2005EP1299382B1 Composition and antiviral activity of substituted indoleoxoacetic piperazine derivatives
09/21/2005EP1265862B1 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses
09/21/2005EP1096934B1 Oxazolidinones to treat eye infections
09/21/2005CN1671711A Calcitonin gene related peptide receptor antagonists
09/21/2005CN1671703A Method for preparing fused oxazinones from ortho-amino aromatic carboxylic acid and a carboxylic acid in the presence of a sulfonyl chloride and pyridine
09/21/2005CN1671702A Pyridines and pyrimidines substituted by 4-trifluoromethylpyrazolyl
09/21/2005CN1671700A Substituted alkylamine derivatives and methods of use
09/21/2005CN1671697A Indole, azaindole and related heterocyclic 4-alkenyl piperidine amides
09/21/2005CN1671696A 激酶抑制剂 Kinase inhibitors
09/21/2005CN1671695A Pyrrolidinedione substituted piperidine-phthalazones as PDE4 inhibitors
09/21/2005CN1671667A Quinoline derivatives and their use as mycobacterial inhibitors
09/21/2005CN1671666A Vegfr-2 and vegfr-3 inhibitory anthranylamidopyridines
09/21/2005CN1671662A Piperidine derivative, process for producing the same, and use
09/21/2005CN1671659A Novel substituted indoles
09/21/2005CN1671386A Substituted anilinic piperidines as MCH selective antagonists
09/21/2005CN1671379A Hydrazonopyrazole derivatives and their use as therapeutics
09/21/2005CN1219780C Heterocyclic compounds binding chemotactic factor receptor
09/21/2005CN1219768C Quinoline derivatives as inhibitors of MEK enzymes
09/21/2005CN1219759C Intermediate for preparing substitated biphenyl oxazoline compounds
09/21/2005CN1219510C Benzimidazole derivatives as modulators of IgE
09/20/2005US6946478 Compounds
09/20/2005US6946466 Aromatic sulfonamides as peroxynitrite-rearrangement catalysts
09/20/2005US6946462 N-monoacylated derivatives of o-phenylenediamines, their analogs and their use as pharmaceutical agents
09/20/2005CA2285119C Retroviral protease inhibiting compounds
09/20/2005CA2211668C Substituted heterocyclic compounds, preparation method therefor and pharmaceutical compositions containing the same
09/15/2005WO2005085275A1 Inhibitors of hepatitis c virus ns3 protease
09/15/2005WO2005085239A2 PYRROLE-DERIVATIVES AS FACTOR Xa INHIBITORS
09/15/2005WO2005085234A2 Bycyclic anthranilamide derivatives useful as insecticides
09/15/2005WO2005085230A1 4-benzimidazol-2-yl-pyridazine-3-one-derivatives, production and use thereof in medicaments
09/15/2005WO2005085226A1 Mtp inhibiting aryl piperidines or piperazines substituted with 5-membered heterocycles
09/15/2005WO2005085225A1 Novel hydroxy-6-heteroarylphenanthridines and their use as pde4 inhibitors
09/15/2005WO2005085216A1 Isoxazoline-substituted benzamide compound and noxious organism control agent
09/15/2005WO2005085212A1 Substituted pyrimidine derivative
09/15/2005WO2005085201A1 Novel cyclic compound having 4-pyridylalkylthio group having (un)substituted amino introduced therein
09/15/2005WO2005085198A2 Amino cyclopropane carboxamide derivatives as bradykinin antagonists
09/15/2005WO2005085194A2 Indole-2-carboxylic acid hydrazides as glycogen phosphorylase inhibitors
09/15/2005WO2005068433A9 Benzimidazole derivatives
09/15/2005WO2005065050A3 Bicyclic compound
09/15/2005WO2005055940A3 Novel m3 muscarinic acetylcholine receptor antagonists
09/15/2005WO2005054430A3 Hepatitis c virus inhibitors
09/15/2005WO2005051300A3 Bicyclic inhibitors of mek and methods of use thereof
09/15/2005WO2005049589A3 Heterocyclic compounds for the treatment of hyperlipidemia, diabetes, obesity and similar diseases
09/15/2005WO2005049563A3 Efficient nucleotide synthesis
09/15/2005WO2005039496A3 Inhibitors of cathepsin s
09/15/2005WO2005026111A3 Heteroaromatic selective inhibitors of neuronal nitric oxide synthase
09/15/2005WO2005000404A3 Heterocyclic compounds for preventing and treating disorders associated with excessive bone loss
09/15/2005WO2004091514A3 Cgrp receptor antagonists
09/15/2005US20050203294 Process for the preparation of benazepril hydrochloride
09/15/2005US20050203173 PI-3 kinase inhibitor prodrugs
09/15/2005US20050203153 Drugs with carriers as prodrugs for anticancer agents
09/15/2005US20050203151 carboxy- or tetrazole functional thiazole and oxazole compounds; peroxisome proliferator-activated receptor (PPAR) modulators; Type 2 diabetes, syndrome X, dyslipidemia, and atherosclerotic diseases
09/15/2005US20050203147 Biaryl heterocyclic compounds and methods of making and using the same
09/15/2005US20050203146 P2Y1 Purinoreceptor; thromboembolic disorders; compounds are 2-((hetero)arylamino) benzimidazoles, benzoxazoles or benzothiazoles such as [2-(2-tert-butyl-phenoxy)-pyridin-3-yl]-(6-methyl-1H-benzoimidazol-2-yl)-amine
09/15/2005US20050203144 Use against multi-drug resistant staphylococci, streptococci, enterococci, Bacteroides, Clostridia, Mycobacterium tuberculosis; e.g. N-[5(S)-3-[3,5-Difluoro-4-[(1alpha,5alpha,6alpha )-6-[(2-(1,3-dihydroxy)propyloxy)iminomethyl]-3-azabicyclo[3.1.0]hexan-3-yl]phenyl]-2-oxooxazolidin-5-ylmethyl]acetamide
09/15/2005US20050203127 2-(Phenyl)-2h-pyrazole-3-carboxylic acid-n-4-(thioxo-heterocyclyl)-phenyl-amide derivatives and corresponding imino-heterocyclyl derivatives and relates compounds for use as inhibitors of the coagulation factors xa and/or viia for treating thromboses
09/15/2005US20050203114 Pyrimidine-indole derivatives; cancer, autoimmunological, metabolic, inflammatory, infection (bacterial, viral, yeast, fungal, etc.), diseases of the central nervous system, degenerative neural disease, allergy/asthma, dermatology, angiogenesis, neovascularization, vasculogenesis, and cardiovascular
09/15/2005US20050203102 Oxazolidinone derivatives such as (S)-N-[3-[3-fluoro-4-[4-[4-[(3-carboxymethyl-5-oxo-2-thioxo-1,3-thiazolidin-3-yl)methine]phenyl]piperazin-1 -yl]phenyl]-2-oxooxazolidin-5-ylmethyl] acetamide; antibiotics; use against Vancomycin resistant organisms, methicillin resistant organisms
09/15/2005US20050203101 Benzimidazole quinolinones and uses thereof
09/15/2005US20050203093 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4
09/15/2005US20050203090 Methods of using N-alkyl-hydroxamic acid-isoindolyl compounds
09/15/2005US20050203089 N-substituted prodrugs of fluorooxindoles
09/15/2005US20050203078 Inhibitors of factor Xa or related serine proteases; thrombosis; benzamide derivatives with benzimidazole, indole or imidazo(1,2-a)pyridine rings; e.g. 4-(azepan-2-on-1-yl)-N-[(1R)-1-(5-chloro-1H-benzimidazol-2-yl)-2-methoxy-ethyl]-3-methyl-benzamide
09/15/2005US20050203064 Novel oxidized thioether derivatives
09/15/2005CA2558848A1 Isoxazoline-substituted benzamide compound and pesticide
09/15/2005CA2557858A1 Amino cyclopropane carboxamide derivatives as bradykinin antagonists
09/15/2005CA2557322A1 Inhibitors of hepatitis c virus ns3 protease
09/15/2005CA2557270A1 Pyrrole-derivatives as factor xa inhibitors
09/15/2005CA2556387A1 Bicyclic anthranilamide derivatives useful as insecticides
09/15/2005CA2555712A1 Novel cyclic compound having 4-pyridylalkylthio group having substituted or unsubstituted amino group introduced therein
09/14/2005EP1574510A1 Substituted pyridine herbicides
09/14/2005EP1574504A1 Benzomorpholine derivatives
09/14/2005EP1572688A1 Oxazolidinone derivatives and their use as antibacterial agents
09/14/2005EP1572687A1 Antibacterial oxazolidinones
09/14/2005EP1572681A1 3-substituted-4-pyrimidone derivatives
09/14/2005EP1572672A1 Benzoxazocines and their use as monoamine-reuptake inhibitors
09/14/2005EP1572671A1 Non-steroidal anti-inflammatory agents
09/14/2005EP1572670A1 5-substituted-pyrazine or -pyridine glucokinase activators
09/14/2005EP1572669A2 2,5-diketopiperazines for the treatment of obesity
09/14/2005EP1572668A2 N-(substituted arylmethyl)-4-(disubstituted methyl)piperidines and piperazines
09/14/2005EP1572667A1 Cathepsin cysteine protease inhibitors and their use
09/14/2005EP1572664A1 Pyrazole compounds
09/14/2005EP1572662A1 Pyrazole and imidazole compounds and uses thereof
09/14/2005EP1572655A2 Novel arylheteroalkylamine derivatives
09/14/2005EP1572642A1 3-pyrrolyl urea derivatives and their use as antiviral agents
09/14/2005EP1572215A1 Benzo[d]azepine derivatives for the treatment of neurological disorders
09/14/2005EP1572214A1 Morpholine derivatives for use as dopamine agonists in the treatment of i.a. sexual dysfunction
09/14/2005EP1572207A1 N-(substituted arylmethyl)-4-(disubstituted methyl) piperidines and pyridines
1 ... 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367 368 369 370 371 ... 647